CJC-1295 with DAC

CJC-1295 with DAC, also known as Drug Affinity Complex, is a synthetic peptide categorized under the growth hormone-releasing hormone (GHRH) group. It operates by stimulating the pituitary gland to release growth hormone (GH) and insulin-like growth factor 1 (IGF-1) into the bloodstream. Unlike its counterpart without DAC, CJC-1295 with DAC has an extended half-life, requiring less frequent dosing for sustained GH elevation. It is frequently employed in research and clinical studies to explore its potential in treating growth hormone deficiency, enhancing muscle mass, bone density, and overall metabolic function. However, its usage should be supervised by medical professionals due to potential side effects and regulatory considerations.